AstraZeneca Manufacturer

Listing Websites About AstraZeneca

Filter Type:


Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca

(Right now) HALLE/SAALE, Germany, January 3, 2014 – Probiodrug AG (Probiodrug) announced today the transfer of its experimental cyclin-dependent kinase 9 (CDK9) inhibitor program to AstraZeneca (LSE: AZN, Nasdaq: AZN). The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and ...

Url:  Visit Now 

Category:  Health Detail Drugs 


AstraZeneca resumes Phase 3 COVID-19 vaccine trial in the U.K.

(Right now) AstraZeneca, one of the pharmaceutical companies developing a COVID-19 vaccine, announced over the weekend that clinical trials in the U.K. have resumed. The company got the green light from the Medicines Health Regulatory Authority that continuing to test the vaccine was safe. Last week, AstraZeneca put its Phase 3 trial on hold after a participant became ill. This was a routine action to ensure the safety and integrity of the trial, AstraZeneca said in its statement.

Url:  Visit Now 

Category:  Health Detail Drugs 


Third jab 'significantly' boosts Omicron antibodies: AstraZeneca

(Right now) British pharmaceutical giant AstraZeneca said Thursday that a third, or "booster", dose of its Covid-19 vaccine Vaxzevria "significantly" lifted antibody levels against the Omicron strain in a laboratory study. "Vaxzevria significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529) following a third dose booster," the company said in a statement citing the study. "The third dose booster vaccination neutralised the Omicron variant to levels that were broadly similar to ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1, Upcoming Webinar Hosted by Xtalks | Indica Labs

(Right now) Integration Between Artificial Intelligence and Digital Pathology at AstraZeneca – Broadcast 1, Upcoming Webinar Hosted by Xtalks Join Daniel Sutton, Senior Scientist, Digitisation and AI, Clinical Pharmacology and Safety Science at AstraZeneca for an informative session about AI-based models in the quantification of pathology images. There will be two live broadcasts, on Monday, May 11, 2020 at 11am EDT (4pm BST/UK) and Tuesday, May 12, 2020 at 9am BST/UK. Artificial intelligence (AI) is revolutionizing drug discovery ...

Url:  Visit Now 

Category:  Health Detail Drugs 


AstraZeneca partners with RenalytixAI in chronic disease pact

(Right now) AstraZeneca has linked with RenalytixAI to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases. In the first stage in the partnership, the companies will use KidneyIntelX, an artificial intelligence-enabled in vitro diagnostic platform, to look at further improving outcomes for patients with chronic kidney disease (CKD) and its complications, in coordination with the Mount Sinai Health System. The goal of this is to help boost guideline-based standard-of-care ...

Url:  Visit Now 

Category:  Health Detail Drugs 


AstraZeneca to present immuno-oncology pipeline progress at AACR - Pf Media

(Right now) AstraZeneca will share pioneering research and development across its oncology portfolio and extensive next-generation pipeline at the American Association for Cancer Research (AACR) Annual Meeting in Atlanta, USA, 29 March to 3 April 2019. The new research will showcase AstraZeneca’s potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor, taking the DNA Damage Response (DDR) pipeline beyond PARP inhibition. Additional highlights include new insights from the MYSTIC and TATTON trials for Imfinzi ...

Url:  Visit Now 

Category:  Health Detail Drugs 


NAFDAC Archives

(Right now) COVID-19: NAFDAC approves AstraZeneca vaccine for use in Nigeria The National Agency for Food and Drug Administration and Control, NAFDAC, has approved Oxford/AstraZeneca COVID-19 vaccine for use in Nigeria. NAFDAC Director-General, Dr. Mojisola Adeyeye disclosed...

Url:  Visit Now 

Category:  Health Detail Drugs 


Middle East Boosts Vaccination Efforts - The Media Line

(Right now) Afghanistan starts inoculation drive among other regional improvements, Lebanese legislators jump queue Vaccination efforts in the MENA region have increased this week, bolstered by Afghanistan starting its inoculation campaign Tuesday, with enough of the India-produced AstraZeneca vaccine to inoculate a quarter of a million people. Morocco is set to obtain 1 million doses of the AstraZeneca vaccine on February 25 and is scheduled to obtain 13 million more by the beginning of April, mostly from China. The Egyptian ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Nexium Lawsuit Claims PPI - Parker Waichman LLP

(Right now) The Nexium lawsuit accuses AstraZeneca, L.P. and AstraZeneca Pharmaceuticals, L.P. of negligence, negligent misrepresentation and product defects, and seeks exemplary damages. Nexium belongs to a class of drugs known as proton pump inhibitors, or PPIs. Other prescription drugs in that class include Dexilant, Prilosec, Zegerid, Prevacid, Protonix, Aciphex, and Vimivo. PPIs are also available in over-the-counter (OTC) versions like Prilosec OTC, Zegerid OTC and Prevacid 24HR.These drugs are approved to ...

Url:  Visit Now 

Category:  Health Detail Drugs 


COVID-19

(Right now) The COVID-19 pandemic and investigations into the Oxford-AstraZeneca vaccine and blood clots are rapidly evolving situations. This information may be superseded by later findings. This article was … Continue reading →

Url:  Visit Now 

Category:  Health Detail Drugs 


Disney Cruise Line Guests Required to Be Fully Vaccinated For COVID-19

(Right now) -based AstraZeneca or Novavax COVID-19 vaccine trials the second dose of any “mix-and-match” combination of accepted COVID-19 vaccines (administered at least 17 days apart) As of right now, Disney Cruise Line will only accept the following vaccine types: Pfizer, Moderna, Johnson & Johnson, AstraZeneca, Covishield, Novavax, Sinopharm, and Sinovac. In order to sail, all Guests (adults and children, regardless of age) must upload their proof of vaccination. This must be done on the Safe Passage website by ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Sickle Cell Anemia Therapy Candidate Ticagrelor Already Approved...

(Right now) Its maker, AstraZeneca, is also looking at it as a potential treatment for sickle cell disease. AstraZeneca markets ticagrelor in the United States under the brand name Brilinta and Brilique in the rest of the world. People who have had a heart attack use it to reduce their risk of developing blood clots and having a stroke or another heart attack. AstraZeneca is investigating whether ticagrelor could be an effective way to reduce blood vessel blockages in sickle cell disease patients.

Url:  Visit Now 

Category:  Health Detail Drugs 


Per Falk - Ferring Global

(Right now) He previously held executive and senior leadership positions in research, medical and clinical development at Novo Nordisk and AstraZeneca. Before joining industry, he held the position of Associate Professor at the Karolinska Institute, Sweden, and Washington University School of Medicine, USA. Per has an M.D. degree and a Ph.D. in Biochemistry and Clinical Chemistry from Gothenburg University, Sweden.

Url:  Visit Now 

Category:  Health Detail Drugs 


FDA approves starting dose of roflumilast

(Right now) The Food and Drug Administration has approved the use of a 250-mcg dose of roflumilast for patients with chronic obstructive pulmonary disease (COPD) for 4 weeks, followed by the use of 500-mcg therapeutic doses, according to a statement from the drug’s marketer, AstraZeneca. The larger doses of roflumilast ( Daliresp ) are currently indicated for reducing the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations, according to the ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Vaccines too little, too late for Nepal?

(Right now) Denmark announces 250,000 AstraZeneca doses to Bhutan. Japan pledges surplus AZ vaccines to Sri Lanka and the Pacific Islands. Nepal is never in the news, even though 1.4 million people still wait for their second doses of Covishield AZ vaccines and another 20 million people need to be inoculated before a possible third wave this year. So far, Nepal has only been gifted or bought vaccines from India, China or the COVAX initiative.

Url:  Visit Now 

Category:  Health Detail Drugs 


Glenmark Pharmaceuticals gets USFDA nod for sales of stomach relief capsules

(Right now) Mumbai-based pharmaceutical firm Glenmark Pharmaceuticals said it received final approval from the United States Food and Drug Administration (USFDA) for sales of a generic equivalent of AstraZeneca Pharmaceuticals’ Nexium-Delayed Release capsules. • Esomeprazole magnesium capsules are used to treat certain stomach and esophagus problems such as acid reflux and ulcers. It relieves symptoms such as heartburn, difficulty in swallowing and persistent cough. • The medication, which belongs to a class of drugs ...

Url:  Visit Now 

Category:  Health Detail Drugs 


A third of healthcare workers took sick leave after Covid vaccination, study finds - Medical Update Online

(Right now) To find out more, Julia Reusch, of the University Hospital Würzburg, Würzburg, Germany and her colleagues Isabell Wagenhäuser, Dr Alexander Gabel, Dr Manuel Krone and Dr Nils Petri evaluated healthcare workers given at least one dose of the four following COVID-19 vaccines: BioNTech/Pfizer (Comirnaty), Moderna (Spikevax), Oxford/AstraZeneca (VaxZevria) and Janssen. An electronic questionnaire was used to gather information about sick leave and side effects from the 1,797 healthcare workers (aged 18-plus) ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Tinnitus, COVID-19, & COVID-19 Vaccine Side Effects

(Right now) A recent study in the United Kingdom looked at side effects from the Pfizer and the AstraZeneca vaccines. 20 million doses were administered during the period of the study, and individuals were encouraged to report side effects via the Yellow Card reporting system. Ultimately, a total of 116,000 adverse effects were reported, and out of those a total of 780 individuals reported tinnitus. This comes out to fewer than one in 32,000 people, thus classifying tinnitus as a very rare side effect. This is a ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Goserelin Acetate

(Right now) Goserelin was approved in January 1996 by the US Food and Drug Administration (FDA), and is currently commercialized by AstraZeneca under the brand name Zoladex. The original 3.6 mg formulation of Zoladex was already available since 1989 as a monthly implant. The further approval was based on a study that demonstrated that both a goserolin 10.8 mg or 3.6 mg formulation is as effective as surgical castration through an orchiectomy in controlling the spread of prostate cancer. The findings were faced as a ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Biofil Chemicals (BIOFILCHEM) forecast target analysis (Buy Sell recommendations) Biofil Chemicals (BIOFILCHEM) share price targets today Closing Price Charts analysis

(Right now) Astrazeneca Pharma has performed better than Biofil Chemicals in short term. You could have earned much better returns by investing in Astrazeneca Pharma, about 1.12% more returns! Biofil Chemicals has performed better than Alembic in short term. Holding Biofil Chemicals could be a better choice for now!

Url:  Visit Now 

Category:  Health Detail Drugs 


Seroquel Withdrawal: Symptoms, Risks And Timeline

(Right now) Biomolecules & therapeutics, 21(4), 307. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819904/ ASTRAZENECA CANADA INC. PART III: CONSUMER INFORMATION SEROQUEL® quetiapine fumarate immediate-release tablets, 2019. https://www.astrazeneca.ca/content/dam/az-ca/downloads/productinformation/seroquel-consumer-information-leaflet-en.pdf Brandt, L., Bschor, T., Henssler, J., Müller, M., Hasan, A., Heinz, A., & Gutwinski, S. (2020). Antipsychotic withdrawal symptoms: a systematic review and meta-analysis. ...

Url:  Visit Now 

Category:  Health Detail Drugs 


AstraZeneca to collaborate with South Summit to drive innovation

(1 day(s) ago) The pharmaceutical company AstraZeneca has reached an agreement with the South Summit startup platform to work together to boost the innovative ecosystem in Spain. The British company will join South Summit's network of startups, entrepreneurs and companies focused on health and new technologies, and will promote the development of disruptive solutions through synergies with the Spanish organisation. The aim of the partnership is to identify solutions that can have a real impact on patient health and quality of life in ...

Url:  Visit Now 

Category:  Health Detail Drugs 


AstraZeneca Acquiring Alexion in $39 Billion Immunology Buy-Out - Healthcare Weekly

(1 day(s) ago) AstraZeneca, the developer of one of the pharmaceutical industry’s first COVID-19 vaccine, recently announced that it will acquire US-based Alexion for $39 billion. Under the terms of the agreement, AstraZeneca, British-Swedish multinational pharmaceutical and biopharmaceutical company, indicated that Alexion shareholders will receive $60 in cash and around 2.1 from the company’s US-listed shares for each share of Alexion they own. Alexion Pharmaceutical is valued at $175 per share, a 45% premium ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Comparison of Pfizer, Moderna, J&J, AZ vaccines for neutralization titer, against Delta and other variants

(1 day(s) ago) Four current vaccines — Moderna, Pfizer-BioNTech, Johnson & Johnson, and AstraZeneca — are highly effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but a new medRxiv* study suggests the level of protection varies. Researchers from The Netherlands found the mRNA vaccines produce more antibodies than adenovirus-based vaccines. “The implication is that individuals receiving one of the adenovirus vector-based vaccines are more vulnerable to infection with the Beta and Delta ...

Url:  Visit Now 

Category:  Health Detail Drugs 


SpicyIP

(1 day(s) ago) Topical Highlight COVID-19 Vaccines: Patent Ownership and the Barriers to Equitable Access In this post, Adyasha conducts a thorough analysis of the vaccines developed by Moderna, Pfizer-BioNTech and AstraZeneca-Oxford, the complex ownership status of their intellectual property, the bilateral pre-purchase deals struck with higher-income countries and their implications on the Global South. She first notes the importance of public funding for the fruition of the three vaccines upon which patent protection ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes

(1 day(s) ago) Dr Bethel has received no personal payments for participation in these trials: Steering Committee member, SOUL (semaglutide), Novo Nordisk; Steering Committee member, BEST (bexagliflozin), Theracos; Clinical Lead, TECOS (sitagliptin), Merck; Global Clinical Lead, EXSCEL (exenatide), AstraZeneca; Principal Investigator and National Coordinator, HARMONY (albiglutide), GSK; Data Monitoring Committee member, DEVOTE (degludec), Novo Nordisk; and Data Monitoring Committee member, DEFINE-HF (dapagliflozin), AstraZeneca. Dr Bethel has also participated in advisory boards for ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Shetal Vyas - Ferring Pharmaceuticals USA

(1 day(s) ago) Shetal began her career in sales at AstraZeneca where she rose to positions of increasing responsibility. Shetal holds an MBA in Marketing from St. Joseph’s University in Philadelphia and a Bachelor of Science degree in Health Studies from Temple University also in Philadelphia.

Url:  Visit Now 

Category:  Health Detail Drugs 


VIDEO: Positive trial results on selective estrogen receptor degrader 'exciting'

(1 day(s) ago) VIDEO: Positive trial results on selective estrogen receptor degrader 'exciting' Source/Disclosures Disclosures: Krop reports salary from AMAG Pharmaceuticals and Freeline Therapeutics; consulting fees from AstraZeneca, Bristol-Myers Squibb, Context Therapeutics, Daiichi Sankyo, Genentech/Roche, Ionis Pharmaceuticals/Novartis, Macrogenics, Merck, Seattle Genetics and Taiho Pharmaceutical; contracted research from Genentech and Pfizer; ownership interest in AMAG Pharmaceuticals, Freeline Therapeutics and Vertex; receiving ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Home - Next Gen Lipid-Based Nanoparticles Delivery Summit

(1 day(s) ago) Join Intellia Therapeutics , Entos Pharmaceuticals , AstraZeneca , Eli Lilly , and other scientific trailblazers as they navigate the next generation of lipid-based nanoparticles for targeted delivery to expedite innovative treatments for unmet patient needs.

Url:  Visit Now 

Category:  Health Detail Drugs 


On-Demand Webinar: Discover the Capsugel® Zephyr™ Dry-Powder Inhalation Portfolio | Capsugel

(1 day(s) ago) Frédérique has been working in the pharmaceutical industry for more than 20 years: first at AstraZeneca UK, working on analytical development of therapeutic proteins and antibodies, then at CDMO Bertin Pharma (now Eurofins), working mainly on generic product development and licensing out. Frédérique joined Capsugel® in 2010 as Pharmaceutical Business Development Manager, providing technical and regulatory support for new capsule-based product developments. • Frédérique has developed specific expertise ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Pfizer Denies Lipitor Contributes to Type-2 Diabetes

(1 day(s) ago) Past settlements by pharmaceutical companies include AstraZeneca settling for $647 million for damages caused by its product Seroquel and Bayer settling for $1 billion for damages caused by its product Baycol, a statin similar to Lipitor. Prospective plaintiffs against Pfizer will ultimately face issues as to what degree Lipitor increased the risk of type-2 diabetes in respective users and whether the risk of type-2 diabetes was negligible in comparison to the benefits Lipitor provided to these users. If ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Asigurări - Humanitas.net

(1 day(s) ago) IntegrativaDirigenti AssociazioneVolontariItaliani di Corsico ASTRAZENECA S.p.a. BANCA POP di ABBIATEGRASSO BANCA POPOLARE DI BRESCIA BANCA POPOLARE DI NOVARA BETTINI ASCENSORI Srl BMW ITALIA S.p.a. C.C.R.S. – GRUPPO UNICREDITO ITALIANO C.I.A.S.D. SOLVAY SPA CADGI – IBM CLOD Srl COFACE ASSICURAZIONI Spa COMFACTOR COMMERCIO FACTORING S.p.a.

Url:  Visit Now 

Category:  Health Detail Drugs 


COVID-19 Vaccines Are Absolutely Safe | Blog | Pharmearth

(1 day(s) ago) Vaccines like AstraZeneca’s COVID-19 vaccine, Janssen’s COVID-19 vaccine & Novavax’s COVID-19 vaccine was under phase three clinical trials till december 2020. Quite recentlyIndia’s drug regulator has given the green light to Covishield (the local name for the Oxford-AstraZeneca vaccine developed in the UK) and Covaxin, locally-made by India’s pharma company Bharat Biotech & India has begun a huge inoculation drive throughout the country along with shipping huge doses to its neighboring countries & as a ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Western News - Western community shares personal reasons for vaccination

(1 day(s) ago) I got both of my shots as soon as I was eligible to: AstraZeneca first and then Pfizer (but would have taken any shot available). I strongly believe the clear scientific evidence that vaccination makes me much less likely to become infected by COVID-19, and therefore makes it much less likely that I infect others. Like most things in biology, protection is not 100 per cent, but by getting the vaccine, my chances of infection are much, much lower. Thus, I got the vaccine to protect myself, which will ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Covaxin vs Covishield: What we know about India’s COVID-19 vaccines?

(1 day(s) ago) Bharat Biotech’s Covaxin and Oxford University’s developed Covishield in partnership with AstraZeneca, now being manufactured by Serum Institute of India, Pune are two India’s manufactured Covid vaccines currently in use in India. Both are similar in some ways, but they are vastly different in others. In collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology, Hyderabad-based Bharat Biotech International Limited developed Covaxin, an inactivated vaccine. ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Journal of Family Medicine & General Practice | USA Journals

(1 day(s) ago) Currently, the European Commission has licensed four vaccines: BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech), mRNA-1273 vaccine Spikevax (formerly COVID-19 Moderna vaccine, ChAdOx1 nCoV-19 vaccine (AstraZeneca vaccine), and the Janssen/Johnson & Johnson vaccine. In Spain, these four vaccines are currently available [7]. The benefits of these vaccines are substantial, and their rapid implementation is an important public health achievement [8]. Existing vaccine-effectiveness estimates have focused ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Europe Industrial Heat Pump Market | Regional Outlook 2027

(1 day(s) ago) However, few pharmaceutical companies which includes, AstraZeneca, Pfizer, Bharat Biotech etc. have developed vaccine for the COVID-19 and it is anticipated that the market share of industrial heat pump industry will rebound back to normalcy by second half of FY 2021. • The study demonstrates a comprehensive analysis of industry trends across Europe segmented across product and application on a country basis. Furthermore, the market forecasts & estimates are suitably associated with the data specified by ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Living with Nano Bots. How to AVOID and CLEAR them!

(1 day(s) ago) Posted on April 3, 2016 by Ramola D | Updated 6/22/2021 For information on how to detox and cleanse out the mRNA lipid nanoparticles or spike protein from the Pfizer/Moderna/AstraZeneca/Johnson & Johnson COVID vaccines, please scroll down to the section titled DETOX AND CLEANSE OUT mRNA AND LIPID NANOPARTICLES AND SPIKE PROTEINS, JUNE 22, 2021 For information on detoxing heavy metals like aluminium from vaccines, please scroll down to DETOX AND CLEANSE FROM ALUMINIUM IN VACCINES TO IMPROVE NEURO HEALTH, ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Philippine officials defend AstraZeneca vaccine deal

(2 day(s) ago) Metro Manila (CNN Philippines, November 27) — Government officials admitted about risks in signing an agreement with AstraZeneca for the purchase of around 2.6 million doses of coronavirus vaccine, but it's a risk the country needed to take. Vaccine czar Carlito Galvez, Jr. and Presidential Adviser for Entrepreneurship Joey Concepcion on Friday led the signing of the tripartite agreement with the British-Swedish drug maker and some of the biggest names in business, who pitched in to secure vaccine supply. Galvez and ...

Url:  Visit Now 

Category:  Health Detail Drugs 


CNBC: Global pharma giant AstraZeneca strikes $6.9 billion deal to expand cancer portfolio

(2 day(s) ago) AstraZeneca has agreed to a $6.9 billion collaboration with Japanese drugmaker Daiichi Sankyo to bolster its oncology franchise. Rather than a full acquisition, it’s agreed to pay for the shared rights for a new cancer drug called DS-8201. AstraZeneca plans to raise up to $3.5 billion through a share placing to fund the transaction as well as pay down debt. Analysts generally see the deal as a logical strategic move but note the equity raise may disappoint some investors.

Url:  Visit Now 

Category:  Health Detail Drugs 


Dr Richard Weaver

(2 day(s) ago) In that time he has gained and developed an in-depth knowledge of all aspects of in vitro and in vivo DMPK, from hit identification to candidate drug nomination and beyond from his experience at AstraZeneca. After leaving AstraZeneca, Richard set up XenoGesis in 2011, which grew to be the UK’s largest independent DMPK provider, before becoming part of Sygnature Discovery in 2020. Richard has a BA and a DPhil in medicinal chemistry from the University of Leicester, and undertook post-doctoral research at ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Booster jabs could prevent Omicron deaths, study finds | The Week UK

(2 day(s) ago) Faust and his team measured immune responses in nearly 3,000 people who received one of seven Covid-19 boosters or a control jab, two to three months after getting a second dose of either the AstraZeneca or Pfizer vaccine. Trial participants boosted with Pfizer following two doses of AstraZeneca “had antibody levels a month later nearly 25 times higher than controls”, The Guardian reported. When Pfizer was used for all three jabs, antibody levels rose more than eightfold. But the “most potent booster” was found to be ...

Url:  Visit Now 

Category:  Health Detail Drugs 


May 2014 - Page 17 of 20 - KRS Global Biotechnology

(2 day(s) ago) AstraZeneca’s board rejected a $106.5 billion bid from predator Pfizer just hours after it was received, arguing that it is too low. The potential takeover of AstraZeneca by Pfizer seemed to have moved a step closer Friday after the world’s biggest pharmaceutical company tempted the U.K. group’s shareholders with a raised bid. The increase from an earlier offer of […]

Url:  Visit Now 

Category:  Health Detail Drugs 


Our Team are Experts in Global Brand Naming | Origin Branding

(2 day(s) ago) Major clients include DowDuPont, Sanofi, BASF, Novo Nordisk, GlaxoSmithKline, Volvo, Bayer, Syngenta, Astellas, Menarini, FreseniusKabi, AstraZeneca, Alcatel, Procter & Gamble, Serono, Siemens, Johnson & Johnson, Allergan, Baxter and Philips. Prior to working in the UK, Rick held a senior management position in a US brand consultancy and worked with Procter & Gamble and State Street Bank in Boston and Hong Kong on international marketing assignments. Rick received an MBA from the Tuck School at Dartmouth ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Dapagliflozin Reduces Risk of Kidney Failure - Pharmacy Near Me

(2 day(s) ago) Recently was confirmed, that treatment with dapagliflozin (Farxiga; AstraZeneca) reduced the risk of kidney failure and cardiovascular (CV) or renal death in patients with chronic kidney disease (CKD). The study was confirmed according to results from a phase 3 clinical study. “Detailed results from the ground-breaking Phase III DAPA-CKD trial showed that dapagliflozin on top of standard of care reduced the composite measure of worsening of renal function or risk of cardiovascular (CV) or renal death by 39% compared to ...

Url:  Visit Now 

Category:  Health Detail Drugs 


A quick review of ELRIG Drug Discovery 2014

(2 day(s) ago) Sophie Quick, a student from the University of York, articulately discussed the research behind her poster, carried out during her time at AstraZeneca. There has been no shortage of research lately discussing the benefits of 2D vs 3D culture screening and how 3D is more representative of an state. Sophie’s talk very clearly highlighted one clear cut advantage during a screen for compounds with specific activity, performed in 2D vs 3D: of around 7,000 compounds screened, approximately 80 were hits and ...

Url:  Visit Now 

Category:  Health Detail Drugs 


What kind of drug is Seroquel? | Side Effects | Dosage | Interactions

(2 day(s) ago) Manufactured by AstraZeneca, Seroquel (quetiapine fumarate) is an oral medication that works by affecting neurotransmitter receptors in the brain. The Food and Drug Administration approved Seroquel in 1997 as a psychotropic medication and then again in 2006 for treatment of depressive episodes related to bipolar I and II. It is currently the only agent approved for this purpose. In addition, Seroquel is used as an off-label treatment of other disorders such as alcoholism, post-traumatic stress disorder, ...

Url:  Visit Now 

Category:  Health Detail Drugs 


NTD Drug Discovery Booster Hit-to-lead | DNDi

(2 day(s) ago) The NTD Drug Discovery Booster consortium has engaged eight pharmaceutical companies to date: AbbVie, Astellas, AstraZeneca, Celgene (now part of Bristol-Myers Squibb), Eisai, Merck, Shionogi, and Takeda Pharmaceutical Company Limited. The Global Health Innovative Technology Fund (GHIT Fund), which launched in 2013 to assist international global health research and development partnerships, supported the involvement of the four Japanese companies through grants provided to DNDi, including an initial grant ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Proton Pump Inhibitor (“PPI”) Lawsuit

(2 day(s) ago) PPIs were developed, manufactured and distributed by various pharmaceutical companies, including AstraZeneca, Pfizer, Takeda, Wyeth Pharmaceuticals and Eisai. According to studies, including a 2016 study published in the Journal of American Medical Association (JAMA Internal Medicine), PPIs have been found to potentially increase the risk of kidney damage in patients who take the drugs. PPI lawsuits have recently been filed against the makers of the PPIs, claiming that the drugs cause acute interstitial ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Validity of Electronically Monitored Medication Adherence and Conventional Adherence Measures in Schizophrenia

(2 day(s) ago) Byerly is a paid consultant for Bristol-Myers Squibb, is on the speaker's bureau for Janssen and Bristol-Myers Squibb, and receives current grant funding from Janssen and AstraZeneca. Dr. Rush is on the speaker's bureau for Cyberonics, Inc., Forest Pharmaceuticals, Inc., and GlaxoSmithKline. He is a consultant for Advanced Neuromodulation Systems, Inc., AstraZeneca, Best Practice Project Management, Inc., Bristol-Myers Squibb, Cyberonics, Inc., Eli Lilly and Company, Forest Pharmaceuticals, Inc., Gerson ...

Url:  Visit Now 

Category:  Health Detail Drugs 

FAQ about Astrazeneca

Who makes capivasertib?

AstraZeneca completed a phase I clinical trial in July 2015 that compared two formulations (tablet and capsule) of capivasertib and established the effect of food on the pharmacokinetics, safety and tolerability on capivasertib, in patients with advanced solid tumours (NCT01895946).

What is Iressa used to treat?

Generic Name: gefitinib Gefitinib is used to treat lung cancer. It works by slowing or stopping the growth of cancer cells.

What is AZD4604?

A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.

When did AstraZeneca acquire Alexion?

The $39bn deal, announced in December 2020, is AstraZeneca's largest ever acquisition: allowing it to move further into immunology with an enhanced scientific presence, and giving it Alexion's lead medicine soliris (eculizumab), among four other approved medicines and a pipeline of 11 molecules.